GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Capital expenditures, FY2025
- £1.3B
- YoY, FY2025
- −3.6%
- 5-year CAGR
- +6.4%
- 10-year CAGR
- −0.2%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| FY2025 | £1.3B | −3.6% |
| FY2024 | £1.4B | +6.5% |
| FY2023 | £1.3B | +15.0% |
| FY2022 | £1.1B | +20.3% |
| FY2021 | £950M | −3.9% |
| FY2020 | £989M | −21.8% |
| FY2019 | £1.3B | −5.9% |
| FY2018 | £1.3B | −13.0% |
| FY2017 | £1.5B | +0.1% |
| FY2016 | £1.5B | +11.8% |
| FY2015 | £1.4B | — |